Key Statistics
Market Cap
$12.27M
Shares Outstanding
4.8M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Jul 25, 2011
Round Lot
100
Locale
US
Trading Data
Day Open
$2.63
Day High
$2.63
Day Low
$2.43
Volume
11.9K
VWAP
$2.48
Prev Close
$2.48
Transactions
--
Acc. Volume
--
About BioLineRX Ltd
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
Identifiers
- CIK
- 0001498403
- Composite FIGI
- BBG001Y26LK0
- Share Class FIGI
- BBG001Y26MC7
- Ticker Root
- BLRX
About BioLineRX Ltd (BLRX) Stock
BioLineRX Ltd (BLRX) closed the 2026-09-17 session at $2.53, up 2.02% versus the previous close (+0.05). The stock opened at $2.63 and traded between $2.43 and $2.63 during that session. Session trading volume was 12K shares. The volume-weighted average price (VWAP) is $2.48.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
BioLineRX Ltd has a market capitalization of $12.3 million. BLRX is listed on the XNAS exchange. The company employs approximately 24 people. The recorded listing date is 2011-07-25.
On this page you can find market BLRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.